Translational and Clinical Science

Jul 13, 2023

The NIMML Institute Announces Publication of a Study in Inflammatory Bowel Diseases

May 17, 2023

NIMML Institute's TITAN-X Drug Development Platform Empowers NImmune Biopharma's Global Pivotal Phase 3 Clinical Trials for Omilancor in Ulcerative Colitis

Jun 29, 2020

New insights on how ABA might improve diabetes bring it one step closer to clinical testing in pre-diabetic patients

Jul 03, 2019

Decoding the Interface of Human Immunity and Metabolism

Jan 01, 2018

Leading Immunometabolism

< Previous